ESMO Congress 2026

October 23–27, 2026 · Madrid · 4353 items

tremelimumab

0 people · 0 posts

Floor

02:32
x.com@
Alberto Giovanni Leone shared updated results of the INFINITY trial—which evaluates the combination treatment of tremelimumab and durvalu...
Same topic tremelimumab · 3 people durvalumab723 views7 likes7 reposts1 reply
06:30
aacr.org
Clinical Trials Plenary: New Results from Immunotherapy Regimen Trials
Final Clinical Trials Plenary, 'Advances in Immunotherapy', chaired by Ryan Sullivan (Massachusetts General Hospital). Alberto Giovanni Leone (Istituto Nazionale dei Tumori) presented phase II INFINITY data on tremelimumab plus durvalumab for organ preservation in MSI-high tumours.
Same topic tremelimumab · 3 peopleNo engagement yet
00:00
youtube.comPick
Liver Cancer Awareness Month: updates in treatment strategies and modalities
VJOncology has released a podcast for Liver Cancer Awareness Month in which several experts discuss advances in the treatment of advanced hepatocellular carcinoma and hepatobiliary tumors. Ghassan Abou-Alfa presents the phase 3 EMERALD-3 trial.
Why it matters: The podcast gives PFS and OS figures for STRIDE plus TACE versus TACE in the phase 3 EMERALD-3 trial, offering a concrete comparison for the intermediate-stage HCC setting.
Same topic tremelimumab · 3 peopleNo engagement yet